513
Participants
Start Date
December 13, 2022
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
None (Observational Study)
Not applicable since it's an observational study.
Research Site, Innsbruck
Research Site, Klagenfurt Am W Rthersee
Research Site, Vienna
Research Site, Erpent
Research Site, Leuven
Research Site, Liège
Research Site, Mouscron
Research Site, Woluwe-Saint-Lambert
Research Site, Yvoir
Research Site, Copenhagen
Research Site, Hvidovre
Research Site, Vejle
Research Site, Aschaffenburg
Research Site, Auerbach
Research Site, Augsburg
Research Site, Bamberg
Research Site, Berlin
Research Site, Bonn
Research Site, Cottbus
Research Site, Düsseldorf
Research Site, Flensburg
Research Site, Freiburg im Breisgau
Research Site, Hamburg
Research Site, Hanover
Research Site, Heidelberg
Research Site, Leipzig
Research Site, Marburg
Research Site, München
Research Site, Schleswig
Research Site, Stuttgart
Research Site, V Lklingen
Research Site, Wiesbaden
Research Site, Jerusalem
Research Site, Rehovot
Research Site, Tel Aviv
Research Site, Ancona
Research Site, Bergamo
Research Site, Catanzaro
Research Site, Florence
Research Site, Milan
Research Site, Napoli
Research Site, Padua
Research Site, Palermo
Research Site, Roma
Research Site, Siena
Research Site, Yradate
Research Site, Stockholm
Research Site, Uppsala
Research Site, Basel
Research Site, Chur
Research Site, Lugano
Research Site, Sion
Research Site, Calgary
Research Site, Edmonton
Research Site, Vancouver
Research Site, Kingston
Research Site, Toronto
Research Site, Windsor
Research Site, Montr Al,
Research Site, Saskatoon
Lead Sponsor
AstraZeneca
INDUSTRY